{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:31:08Z","timestamp":1787682668731,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["NO. 2017SZ0006"],"award-info":[{"award-number":["NO. 2017SZ0006"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10143-021-01492-7","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T08:53:40Z","timestamp":1613724820000},"page":"3335-3348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinicopathological characteristics and treatment outcomes of epithelioid glioblastoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Kaijun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9750-084X","authenticated-orcid":false,"given":"Yanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"1492_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/bpa.12295","volume":"26","author":"S Alexandrescu","year":"2016","unstructured":"Alexandrescu S, Korshunov A, Lai SH, Dabiri S, Patil S, Li R, Shih CS, Bonnin JM, Baker JA, Du E, Scharnhorst DW, Samuel D, Ellison DW, Perry A (2016) Epithelioid glioblastomas and anaplastic epithelioid pleomorphic xanthoastrocytomas--same entity or first cousins? Brain Pathol 26:215\u2013223. https:\/\/doi.org\/10.1111\/bpa.12295","journal-title":"Brain Pathol"},{"key":"1492_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3171\/2013.3.JNS121773","volume":"119","author":"R Babu","year":"2013","unstructured":"Babu R, Hatef J, McLendon RE, Cummings TJ, Sampson JH, Friedman AH, Adamson C (2013) Clinicopathological characteristics and treatment of rhabdoid glioblastoma. J Neurosurg 119:412\u2013419. https:\/\/doi.org\/10.3171\/2013.3.JNS121773","journal-title":"J Neurosurg"},{"key":"1492_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13000-016-0506-2","volume":"11","author":"F Behling","year":"2016","unstructured":"Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J (2016) Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol 11:55. https:\/\/doi.org\/10.1186\/s13000-016-0506-2","journal-title":"Diagn Pathol"},{"key":"1492_CR4","doi-asserted-by":"publisher","first-page":"e1763","DOI":"10.1634\/theoncologist.2020-0258","volume":"25","author":"C Birzu","year":"2020","unstructured":"Birzu C, Tran S, Bielle F, Touat M, Mokhtari K, Younan N, Psimaras D, Hoang-Xuan K, Sanson M, Delattre JY, Idbaih A (2020) Leptomeningeal spread in glioblastoma: diagnostic and therapeutic challenges. Oncologist. 25:e1763\u2013e1776. https:\/\/doi.org\/10.1634\/theoncologist.2020-0258","journal-title":"Oncologist."},{"key":"1492_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/nan.12093","volume":"40","author":"A Broniscer","year":"2014","unstructured":"Broniscer A, Tatevossian RG, Sabin ND, Klimo P Jr, Dalton J, Lee R, Gajjar A, Ellison DW (2014) Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma. Neuropathol Appl Neurobiol 40:327\u2013336. https:\/\/doi.org\/10.1111\/nan.12093","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1492_CR6","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, Patel AS, Rizk EB, Suki D, Sawaya R, Glantz M (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2:1460\u20131469. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373","journal-title":"JAMA Oncol"},{"key":"1492_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lungcan.2014.01.023","volume":"84","author":"OT Brustugun","year":"2014","unstructured":"Brustugun OT, Khattak AM, Tromborg AK, Beigi M, Beiske K, Lund-Iversen M, Helland A (2014) BRAF-mutations in non-small cell lung cancer. Lung Cancer 84:36\u201338. https:\/\/doi.org\/10.1016\/j.lungcan.2014.01.023","journal-title":"Lung Cancer"},{"key":"1492_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/nan.12031","volume":"39","author":"KH Clark","year":"2013","unstructured":"Clark KH, Villano JL, Nikiforova MN, Hamilton RL, Horbinski C (2013) 1p\/19q testing has no significance in the workup of glioblastomas. Neuropathol Appl Neurobiol 39:706\u2013717. https:\/\/doi.org\/10.1111\/nan.12031","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1492_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/Nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks N, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Siegler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954. https:\/\/doi.org\/10.1038\/Nature00766","journal-title":"Nature"},{"key":"1492_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11523-014-0319-8","volume":"10","author":"F Day","year":"2015","unstructured":"Day F, Muranyi A, Singh S, Shanmugam K, Williams D, Byrne D, Pham K, Palmieri M, Tie J, Grogan T, Gibbs P, Sieber O, Waring P, Desai J (2015) A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer. Target Oncol 10:99\u2013109. https:\/\/doi.org\/10.1007\/s11523-014-0319-8","journal-title":"Target Oncol"},{"key":"1492_CR11","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1210\/jc.2012-1775","volume":"97","author":"R Elisei","year":"2012","unstructured":"Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F (2012) The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab 97:4390\u20134398. https:\/\/doi.org\/10.1210\/jc.2012-1775","journal-title":"J Clin Endocrinol Metab"},{"key":"1492_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ccr3.2088","volume":"7","author":"MM Finneran","year":"2019","unstructured":"Finneran MM, Georges J, Kakareka M, Moncman R, Enriquez M, Siegal T, Kubicek G, Turtz A, Yocom S, Goldman HW, Barrese J (2019) Epithelioid glioblastoma presenting as aphasia in a young adult with ovarian cancer: a case report. Clin Case Rep 7:821\u2013825. https:\/\/doi.org\/10.1002\/ccr3.2088","journal-title":"Clin Case Rep"},{"key":"1492_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10014-015-0239-z","volume":"33","author":"N Funata","year":"2016","unstructured":"Funata N, Nobusawa S, Yamada R, Shinoura N (2016) A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation. Brain Tumor Pathol 33:57\u201362. https:\/\/doi.org\/10.1007\/s10014-015-0239-z","journal-title":"Brain Tumor Pathol"},{"key":"1492_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/neup.12459","volume":"38","author":"T Furuta","year":"2018","unstructured":"Furuta T, Miyoshi H, Komaki S, Arakawa F, Morioka M, Ohshima K, Nakada M, Sugita Y (2018) Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma. Neuropathology 38:218\u2013227. https:\/\/doi.org\/10.1111\/neup.12459","journal-title":"Neuropathology"},{"key":"1492_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/s1130-1473(09)70133-2","volume":"20","author":"J Gasco","year":"2009","unstructured":"Gasco J, Franklin B, Fuller GN, Salinas P, Prabhu S (2009) Multifocal epithelioid glioblastoma mimicking cerebral metastasis: case report. Neurocirugia 20:550\u2013554. https:\/\/doi.org\/10.1016\/s1130-1473(09)70133-2","journal-title":"Neurocirugia"},{"key":"1492_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"key":"1492_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11060-016-2110-4","volume":"130","author":"SL Hervey-Jumper","year":"2016","unstructured":"Hervey-Jumper SL, Berger MS (2016) Maximizing safe resection of low- and high-grade glioma. J Neuro-Oncol 130:269\u2013282. https:\/\/doi.org\/10.1007\/s11060-016-2110-4","journal-title":"J Neuro-Oncol"},{"key":"1492_CR18","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1016\/j.wneu.2018.12.128","volume":"124","author":"QL Huang","year":"2019","unstructured":"Huang QL, Cao X, Chai X, Wang X, Xiao C, Wang J (2019) The radiological imaging features of easily misdiagnosed epithelioid glioblastoma in seven patients. World Neurosurg 124:e527\u2013e532. https:\/\/doi.org\/10.1016\/j.wneu.2018.12.128","journal-title":"World Neurosurg"},{"key":"1492_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/pin.12896","volume":"70","author":"R Ishikawa","year":"2020","unstructured":"Ishikawa R, Kadota K, Hayashi T, Kimura N, Inoue K, Ibuki E, Kagawa S, Kushida Y, Okada M, Miyake K, Tamiya T, Nobusawa S, Hirato J, Haba R (2020) A rare case of BRAF V600E-mutated epithelioid glioblastoma with a sarcomatous component. Pathol Int 70:166\u2013170. https:\/\/doi.org\/10.1111\/pin.12896","journal-title":"Pathol Int"},{"key":"1492_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40478-019-0774-7","volume":"7","author":"Y Kanemaru","year":"2019","unstructured":"Kanemaru Y, Natsumeda M, Okada M, Saito R, Kobayashi D, Eda T, Watanabe J, Saito S, Tsukamoto Y, Oishi M, Saito H, Nagahashi M, Sasaki T, Hashizume R, Aoyama H, Wakai T, Kakita A, Fujii Y (2019) Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy. Acta Neuropathol Commun 7:119. https:\/\/doi.org\/10.1186\/s40478-019-0774-7","journal-title":"Acta Neuropathol Commun"},{"key":"1492_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.prp.2018.03.019","volume":"214","author":"G Khanna","year":"2018","unstructured":"Khanna G, Pathak P, Suri V, Sharma MC, Chaturvedi S, Ahuja A, Bhardwaj M, Garg A, Sarkar C, Sharma R (2018) Immunohistochemical and molecular genetic study on epithelioid glioblastoma: series of seven cases with review of literature. Pathol Res Pract 214:679\u2013685. https:\/\/doi.org\/10.1016\/j.prp.2018.03.019","journal-title":"Pathol Res Pract"},{"key":"1492_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/PAS.0b013e3181ce107b","volume":"34","author":"BK Kleinschmidt-DeMasters","year":"2010","unstructured":"Kleinschmidt-DeMasters BK, Alassiri AH, Birks DK, Newell KL, Moore W, Lillehei KO (2010) Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6. Am J Surg Pathol 34:341\u2013354. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ce107b","journal-title":"Am J Surg Pathol"},{"key":"1492_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/PAS.0b013e31827f9c5e","volume":"37","author":"BK Kleinschmidt-DeMasters","year":"2013","unstructured":"Kleinschmidt-DeMasters BK, Aisner DL, Birks DK, Foreman NK (2013) Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol 37:685\u2013698. https:\/\/doi.org\/10.1097\/PAS.0b013e31827f9c5e","journal-title":"Am J Surg Pathol"},{"key":"1492_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.25259\/SNI_544_2019","volume":"11","author":"D Kohno","year":"2020","unstructured":"Kohno D, Inoue A, Fukushima M, Aki T, Matsumoto S, Suehiro S, Nishikawa M, Ozaki S, Shigekawa S, Watanabe H, Kitazawa R, Kunieda T (2020) Epithelioid glioblastoma presenting as multicentric glioma: a case report and review of the literature. Surg Neurol Int 11:8. https:\/\/doi.org\/10.25259\/SNI_544_2019","journal-title":"Surg Neurol Int"},{"key":"1492_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/a:1016218117251","volume":"58","author":"A Korshunov","year":"2002","unstructured":"Korshunov A, Golanov A, Sycheva R (2002) Immunohistochemical markers for prognosis of cerebral glioblastomas. J Neuro-Oncol 58:217\u2013236. https:\/\/doi.org\/10.1023\/a:1016218117251","journal-title":"J Neuro-Oncol"},{"key":"1492_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/neup.12258","volume":"36","author":"J Kuroda","year":"2016","unstructured":"Kuroda J, Nobusawa S, Nakamura H, Yokoo H, Ueda R, Makino K, Yano S, Kuratsu J (2016) A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma. Neuropathology 36:181\u2013186. https:\/\/doi.org\/10.1111\/neup.12258","journal-title":"Neuropathology"},{"key":"1492_CR27","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1200\/JCO.2016.71.8726","volume":"35","author":"A Lassaletta","year":"2017","unstructured":"Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M, Krishnatry R, Guerreiro Stucklin A, Zhukova N, Arnoldo A, Ryall S, Ling C, McKeown T, Loukides J, Cruz O, de Torres C, Ho CY, Packer RJ, Tatevossian R, Qaddoumi I, Harreld JH, Dalton JD, Mulcahy-Levy J, Foreman N, Karajannis MA, Wang S, Snuderl M, Nageswara Rao A, Giannini C, Kieran M, Ligon KL, Garre ML, Nozza P, Mascelli S, Raso A, Mueller S, Nicolaides T, Silva K, Perbet R, Vasiljevic A, Faure Conter C, Frappaz D, Leary S, Crane C, Chan A, Ng HK, Shi ZF, Mao Y, Finch E, Eisenstat D, Wilson B, Carret AS, Hauser P, Sumerauer D, Krskova L, Larouche V, Fleming A, Zelcer S, Jabado N, Rutka JT, Dirks P, Taylor MD, Chen S, Bartels U, Huang A, Ellison DW, Bouffet E, Hawkins C, Tabori U (2017) Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J Clin Oncol Off J Am Soc Clin Oncol 35:2934\u20132941. https:\/\/doi.org\/10.1200\/JCO.2016.71.8726","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1492_CR28","doi-asserted-by":"publisher","first-page":"1285729","DOI":"10.1155\/2018\/1285729","volume":"2018","author":"BH Le","year":"2018","unstructured":"Le BH, Close RA (2018) Imaging and histopathologic nuances of epithelioid glioblastoma. Case Rep Surg 2018:1285729\u20131285725. https:\/\/doi.org\/10.1155\/2018\/1285729","journal-title":"Case Rep Surg"},{"key":"1492_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/nop\/npv054","volume":"3","author":"KE Leaver","year":"2016","unstructured":"Leaver KE, Zhang N, Ziskin JL, Vogel H, Recht L, Thomas RP (2016) Response of metastatic glioma to vemurafenib. Neuro-oncol Pract 3:268\u2013271. https:\/\/doi.org\/10.1093\/nop\/npv054","journal-title":"Neuro-oncol Pract"},{"key":"1492_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12957-016-0979-1","volume":"14","author":"C Liu","year":"2016","unstructured":"Liu C, Chen T, Liu Z (2016) Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World J Surg Oncol 14:241. https:\/\/doi.org\/10.1186\/s12957-016-0979-1","journal-title":"World J Surg Oncol"},{"key":"1492_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109. https:\/\/doi.org\/10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"key":"1492_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"1492_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.wneu.2019.08.007","volume":"131","author":"VM Lu","year":"2019","unstructured":"Lu VM, George ND, Brown DA, Akinduro OO, Raghunathan A, Jentoft M, Quinones-Hinojosa A, Chaichana KL (2019) Confirming diagnosis and effective treatment for rare epithelioid glioblastoma variant: an integrated survival analysis of the literature. World Neurosurg 131:243\u2013251 e242. https:\/\/doi.org\/10.1016\/j.wneu.2019.08.007","journal-title":"World Neurosurg"},{"key":"1492_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/neup.12318","volume":"37","author":"N Matsumura","year":"2017","unstructured":"Matsumura N, Nakajima N, Yamazaki T, Nagano T, Kagoshima K, Nobusawa S, Ikota H, Yokoo H (2017) Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma. Neuropathology 37:58\u201363. https:\/\/doi.org\/10.1111\/neup.12318","journal-title":"Neuropathology"},{"issue":"515","key":"1492_CR35","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/j.wneu.2015.10.065","volume":"86","author":"M Miyahara","year":"2016","unstructured":"Miyahara M, Nobusawa S, Inoue M, Okamoto K, Mochizuki M, Hara T (2016) Glioblastoma with rhabdoid features: report of two young adult cases and review of the literature. World Neurosurg 86(515):e511\u2013e519. https:\/\/doi.org\/10.1016\/j.wneu.2015.10.065","journal-title":"World Neurosurg"},{"key":"1492_CR36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.6004\/jnccn.2015.0148","volume":"13","author":"LB Nabors","year":"2015","unstructured":"Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Lawson R, Loeffler JS, Lovely MP, Moots PL, Mrugala MM, Newton HB, Parney I, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Weiss S, Wen PY, McMillian N, Engh AM (2015) Central nervous system cancers, version 1.2015. J Natl Compr Cancer Netw 13:1191\u20131202. https:\/\/doi.org\/10.6004\/jnccn.2015.0148","journal-title":"J Natl Compr Cancer Netw"},{"key":"1492_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/bpa.12887","volume":"30","author":"N Nakagomi","year":"2020","unstructured":"Nakagomi N, Sakamoto D, Hirose T, Takagi T, Murase M, Nakagomi T, Yoshimura S, Hirota S (2020) Epithelioid glioblastoma with microglia features: potential for novel therapy. Brain Pathol 30:1119\u20131133. https:\/\/doi.org\/10.1111\/bpa.12887","journal-title":"Brain Pathol"},{"key":"1492_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/bpa.12572","volume":"28","author":"N Nakajima","year":"2018","unstructured":"Nakajima N, Nobusawa S, Nakata S, Nakada M, Yamazaki T, Matsumura N, Harada K, Matsuda H, Funata N, Nagai S, Nakamura H, Sasaki A, Akimoto J, Hirato J, Yokoo H (2018) BRAF V600E, TERT promoter mutations and CDKN2A\/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Brain Pathol 28:663\u2013673. https:\/\/doi.org\/10.1111\/bpa.12572","journal-title":"Brain Pathol"},{"key":"1492_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.wneu.2018.01.200","volume":"112","author":"N Nitta","year":"2018","unstructured":"Nitta N, Moritani S, Fukami T, Yoshimura Y, Hirai H, Nozaki K (2018) Intraventricular epithelioid glioblastoma: a case report. World Neurosurg 112:257\u2013263. https:\/\/doi.org\/10.1016\/j.wneu.2018.01.200","journal-title":"World Neurosurg"},{"key":"1492_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bpa.12114","volume":"24","author":"S Nobusawa","year":"2014","unstructured":"Nobusawa S, Hirato J, Kurihara H, Ogawa A, Okura N, Nagaishi M, Ikota H, Yokoo H, Nakazato Y (2014) Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation. Brain Pathol 24:239\u2013246. https:\/\/doi.org\/10.1111\/bpa.12114","journal-title":"Brain Pathol"},{"key":"1492_CR41","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/archneurpsyc.1933.02240170113007","volume":"30","author":"E Oldberg","year":"1933","unstructured":"Oldberg E (1933) Hemorrhage into gliomas - a review of eight hundred and thirty-two consecutive verified cases of glioma. Arch Neurol Psychiatr 30:1061\u20131073. https:\/\/doi.org\/10.1001\/archneurpsyc.1933.02240170113007","journal-title":"Arch Neurol Psychiatr"},{"key":"1492_CR42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11060-011-0594-5","volume":"105","author":"RA Olson","year":"2011","unstructured":"Olson RA, Brastianos PK, Palma DA (2011) Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis. J Neuro-Oncol 105:325\u2013335. https:\/\/doi.org\/10.1007\/s11060-011-0594-5","journal-title":"J Neuro-Oncol"},{"key":"1492_CR43","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro-oncology 20:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro-oncology"},{"key":"1492_CR44","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/jnen\/nlx051","volume":"76","author":"D Pratt","year":"2017","unstructured":"Pratt D, Pittaluga S, Palisoc M, Fetsch P, Xi L, Raffeld M, Gilbert MR, Quezado M (2017) Expression of CD70 (CD27L) is associated with epithelioid and sarcomatous features in IDH-wild-type glioblastoma. J Neuropathol Exp Neurol 76:697\u2013708. https:\/\/doi.org\/10.1093\/jnen\/nlx051","journal-title":"J Neuropathol Exp Neurol"},{"key":"1492_CR45","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/cncr.23899","volume":"113","author":"FJ Rodriguez","year":"2008","unstructured":"Rodriguez FJ, Scheithauer BW, Giannini C, Bryant SC, Jenkins RB (2008) Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer 113:2779\u20132789. https:\/\/doi.org\/10.1002\/cncr.23899","journal-title":"Cancer"},{"key":"1492_CR46","doi-asserted-by":"publisher","first-page":"e47054","DOI":"10.1371\/journal.pone.0047054","volume":"7","author":"G Safaee Ardekani","year":"2012","unstructured":"Safaee Ardekani G, Jafarnejad SM, Tan L, Saeedi A, Li G (2012) The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis. PLoS One 7:e47054. https:\/\/doi.org\/10.1371\/journal.pone.0047054","journal-title":"PLoS One"},{"key":"1492_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405. https:\/\/doi.org\/10.1007\/s00401-011-0802-6","journal-title":"Acta Neuropathol"},{"key":"1492_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jager N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Fruhwald MC, Roggendorf W, Kramm C, Durken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231. https:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"key":"1492_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1215\/S1152851702000601","volume":"5","author":"EG Shaw","year":"2003","unstructured":"Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro-oncology 5:153\u2013160. https:\/\/doi.org\/10.1215\/S1152851702000601","journal-title":"Neuro-oncology"},{"key":"1492_CR50","doi-asserted-by":"publisher","unstructured":"Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A (2019) Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics. Cells 8. https:\/\/doi.org\/10.3390\/cells8080863","DOI":"10.3390\/cells8080863"},{"key":"1492_CR51","doi-asserted-by":"publisher","first-page":"CNS48","DOI":"10.2217\/cns-2019-0018","volume":"8","author":"M Smith-Cohn","year":"2019","unstructured":"Smith-Cohn M, Davidson C, Colman H, Cohen AL (2019) Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases. CNS Oncol 8:CNS48. https:\/\/doi.org\/10.2217\/cns-2019-0018","journal-title":"CNS Oncol"},{"key":"1492_CR52","doi-asserted-by":"publisher","first-page":"20150857","DOI":"10.1259\/bjr.20150857","volume":"89","author":"M Smits","year":"2016","unstructured":"Smits M (2016) Imaging of oligodendroglioma. Br J Radiol 89:20150857. https:\/\/doi.org\/10.1259\/bjr.20150857","journal-title":"Br J Radiol"},{"key":"1492_CR53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiation Oncology G, National Cancer Institute of Canada Clinical Trials G (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"1492_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10014-015-0243-3","volume":"33","author":"K Sugimoto","year":"2016","unstructured":"Sugimoto K, Ideguchi M, Kimura T, Kajiwara K, Imoto H, Sadahiro H, Ishii A, Kawano H, Ikeda E, Suzuki M (2016) Epithelioid\/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma. Brain Tumor Pathol 33:137\u2013146. https:\/\/doi.org\/10.1007\/s10014-015-0243-3","journal-title":"Brain Tumor Pathol"},{"key":"1492_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10014-014-0192-2","volume":"31","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Nakada M, Nobusawa S, Suzuki SO, Sabit H, Miyashita K, Hayashi Y (2014) Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation. Brain Tumor Pathol 31:172\u2013176. https:\/\/doi.org\/10.1007\/s10014-014-0192-2","journal-title":"Brain Tumor Pathol"},{"key":"1492_CR56","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","volume":"23","author":"JP Thakkar","year":"2014","unstructured":"Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomark Prev 23:1985\u20131996. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0275","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1492_CR57","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3892\/ol.2018.8919","volume":"16","author":"Z Tosuner","year":"2018","unstructured":"Tosuner Z, Gecer MO, Hatiboglu MA, Abdallah A, Turna S (2018) BRAF V600E mutation and BRAF VE1 immunoexpression profiles in different types of glioblastoma. Oncol Lett 16:2402\u20132408. https:\/\/doi.org\/10.3892\/ol.2018.8919","journal-title":"Oncol Lett"},{"key":"1492_CR58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1227\/00006123-198204000-00004","volume":"10","author":"S Wakai","year":"1982","unstructured":"Wakai S, Yamakawa K, Manaka S, Takakura K (1982) Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery 10:437\u2013444. https:\/\/doi.org\/10.1227\/00006123-198204000-00004","journal-title":"Neurosurgery"},{"key":"1492_CR59","first-page":"1529","volume":"13","author":"S Wang","year":"2020","unstructured":"Wang S, He Q, Zhang Q, Guan B, Zhou X (2020) Clinicopathologic features and prognosis of epithelioid glioblastoma. Int J Clin Exp Pathol 13:1529\u20131539","journal-title":"Int J Clin Exp Pathol"},{"key":"1492_CR60","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1016\/S1470-2045(14)70011-7","volume":"15","author":"M Weller","year":"2014","unstructured":"Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D, Henriksson R, Balana C, Chinot O, Ram Z, Reifenberger G, Soffietti R, Wick W, European Association for Neuro-Oncology Task Force on Malignant G (2014) EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 15:e395\u2013e403. https:\/\/doi.org\/10.1016\/S1470-2045(14)70011-7","journal-title":"Lancet Oncol"},{"key":"1492_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.wneu.2019.04.025","volume":"127","author":"JM Werner","year":"2019","unstructured":"Werner JM, Brunn A, Fink GR, Galldiks N (2019) Magnetic resonance imaging reveals a pronounced treatment response of a isocitrate dehydrogenase- and B-Raf proto-oncogene-wildtype epithelioid glioblastoma. World Neurosurg 127:213\u2013215. https:\/\/doi.org\/10.1016\/j.wneu.2019.04.025","journal-title":"World Neurosurg"},{"key":"1492_CR62","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.18632\/oncotarget.26932","volume":"10","author":"PYM Woo","year":"2019","unstructured":"Woo PYM, Lam TC, Pu JKS, Li LF, Leung RCY, Ho JMK, Zhung JTF, Wong B, Chan TSK, Loong HHF, Ng HK (2019) Regression of BRAF (V600E) mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases. Oncotarget 10:3818\u20133826","journal-title":"Oncotarget"},{"key":"1492_CR63","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.2147\/OTT.S249317","volume":"13","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Zhu X, Wang Y, Liu B, Yang X, Wang Q, Du J, Ma Y, Lin L, Fu P, Xiao H, Guo QN (2020) Clinicopathological, immunohistochemical and molecular genetic study on epithelioid glioblastoma: a series of fifteen cases with literature review. OncoTargets Ther 13:3943\u20133952. https:\/\/doi.org\/10.2147\/OTT.S249317","journal-title":"OncoTargets Ther"},{"key":"1492_CR64","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.18632\/oncotarget.5456","volume":"7","author":"RQ Zhang","year":"2016","unstructured":"Zhang RQ, Shi Z, Chen H, Chung NY, Yin Z, Li KK, Chan DT, Poon WS, Wu J, Zhou L, Chan AK, Mao Y, Ng HK (2016) Biomarker-based prognostic stratification of young adult glioblastoma. Oncotarget 7:5030\u20135041. https:\/\/doi.org\/10.18632\/oncotarget.5456","journal-title":"Oncotarget"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-021-01492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-021-01492-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-021-01492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T17:07:21Z","timestamp":1636996041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-021-01492-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1007\/s10143-021-01492-7","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of West China Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent form for all included cases in our institution was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved the manuscript to be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}